TP53 and congenital bilateral aplasia of vas deferens from CFTR mutation: Senescent VSMCs are now thought to drive CAVD, as there is an accumulation of senescent VSMC, determined by p16inkaand p53-positive expression, in the aortic valves of individuals with advanced CAVD (Oh et al., 2021).